57260-71-6,With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.57260-71-6,tert-Butyl piperazine-1-carboxylate,as a common compound, the synthetic route is as follows.
To a solution of tert-butyl piperazine-1-carboxylate(0.6 g, 3.2 mmol) and triethylamine (4.6 mL, 32 mmol) in anhydrous THF (10 mL)was added trimethylsilyl isocyanate (4.2 mL, 32 mmol) dropwise atrt. The mixture was stirred at rt for 1.5 h and quenched with ice-water (10 mL), and then THF was removed. The aqueous layer was extracted with EtOAc (30 mL ×3) . The combined organic layers were dried over anhydrous Na2SO4and concentrated. The residue was washed with EtOAc (2 mL) by supersonicvibration for 1 min and vacuum filtered to give tert-butyl4-carbamoylpiperazine-1-carboxylate as a white solid (0.3 g, 40) . 1H NMR (400 MHz, CDCl3): delta ppm 3.42-3.49 (m, 4H) , 3.37-3.42 (m, 4H) , 1.49 (s, 9H) and MS-ESI: m/z252.05 [M+Na] + .
57260-71-6 tert-Butyl piperazine-1-carboxylate 143452, apiperazines compound, is more and more widely used in various fields.
Reference:
Patent; SUNSHINE LAKE PHARMA CO., LTD.; ZHANG, Yingjun; LIU, Bing; YU, Tianzhu; ZHANG, Xiangyu; ZHANG, Shiguo; ZHANG, Jiancun; CHENG, Changchung; (426 pag.)WO2016/34134; (2016); A1;,
Piperazine – Wikipedia
Piperazines – an overview | ScienceDirect Topics